Show simple item record

dc.contributor.authorIshii, Tetsuya
dc.contributor.authorDe Miguel Beriain, Iñigo
dc.date.accessioned2020-02-28T14:17:08Z
dc.date.available2020-02-28T14:17:08Z
dc.date.issued2019-11
dc.identifier.citationCRISPR Journal 2(6) : 370-375 (2019)es_ES
dc.identifier.issn2573-1599
dc.identifier.issn2573-1602
dc.identifier.urihttp://hdl.handle.net/10810/41862
dc.description.abstractThe social acceptability of germline genome editing (GGE) depends on its perceived safety, as well as respect for reproductive autonomy. However, it is doubtful that prospective parents sufficiently understand the risks of GGE. In the future, the use of GGE in specific situations seems plausible, as it offers couples potential means to safeguard genetically related future children from a serious disease and overcome infertility due to a gene mutation. Should GGE fail, however, some couples may be obliged to abort affected fetuses, or give birth to adversely affected children, which would be a tragedy. Some children might develop diseases later in life due to overlooked off-target mutations. Compounding this, some parents are unlikely to inform their offspring about the details of conception, hampering necessary follow-up. Prospective parents, scientists and policy makers should carefully discuss the safety implications of GGE for genetically related future children.es_ES
dc.description.sponsorshipThis work was supported by the Uehiro Foundation on Ethics and Education (T.I.), the JSPS KAKENHI Project Innovative Ethics (Graduate School of Humanities, Kobe University, Kobe, Japan; T.I.), and the Government of the Basque Country (Grant IT-1066-16; I.M.B.).es_ES
dc.language.isoenges_ES
dc.publisherMary Ann Liebertes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectgene-therapyes_ES
dc.subjectabortiones_ES
dc.titleSafety of Germline Genome Editing for Genetically Related ‘‘Future’’ Children as Perceivedes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holderThis Open Access article is distributed under the terms of the Creative CommonsLicense (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work isproperly cited.The CRISPR JournalVolume 2, Number 6, 2019Mary Ann Liebert, Inc.DOI: 10.1089/crispr.2019.00103es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://www.liebertpub.com/doi/10.1089/crispr.2019.0010es_ES
dc.identifier.doi10.1089/crispr.2019.0010
dc.departamentoesDerecho publicoes_ES
dc.departamentoeuZuzenbide publikoaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

This Open Access article is distributed under the terms of the Creative CommonsLicense (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work isproperly cited.The CRISPR JournalVolume 2, Number 6, 2019Mary Ann Liebert, Inc.DOI: 10.1089/crispr.2019.00103
Except where otherwise noted, this item's license is described as This Open Access article is distributed under the terms of the Creative CommonsLicense (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work isproperly cited.The CRISPR JournalVolume 2, Number 6, 2019Mary Ann Liebert, Inc.DOI: 10.1089/crispr.2019.00103